Heads up! Binance will delist $ACA, $CHESS, $DATA, $DF, $GHST, and $NKN on February 13, 2026.Details 👉 https://t.co/4pwH0g0vr1 https://t.co/5j2fup00ok ...

Core Viewpoint - Centene Corp. experienced a significant decline in share price due to disappointing updates on Medicare Advantage payments, which are expected to remain flat, leading to investor concerns [1][3]. Group 1: Company Performance - Centene Corp. saw its stock price drop by 10.26% to $41.53, ending a three-day winning streak [1]. - The company's performance is heavily influenced by government-sponsored programs such as Medicare, Medicaid, and ACA [3]. Group 2: Medicare Payment Updates - The Centers for Medicare and Medicaid Services (CMS) projected a net average payment increase of only 0.09%, significantly lower than the anticipated 4 to 6 percent growth [2]. - Proposed tighter risk-adjustment rules by CMS may further impact insurers, including exclusions for diagnoses made solely via audio calls and some chat reviews in 2027 [2]. Group 3: Market Impact - The announcement regarding flat Medicare funding negatively affected the share prices of several insurers, including Centene Corp., UnitedHealth Group, and Oscar Health [3]. Group 4: Future Outlook - Centene Corp. is scheduled to release its earnings results for Q4 and the full year of 2025 on February 6, 2026, with a conference call planned to discuss the outcomes [4]. - Investors are expected to closely monitor the company's outlook in light of updates to government-sponsored programs [4].